<DOC>
	<DOCNO>NCT00613314</DOCNO>
	<brief_summary>To determine efficacy safety telmisartan-based treatment among patient metabolic syndrome actual setting Philippines .</brief_summary>
	<brief_title>Clinical EvaluatioN TElmisartan-based Antihypertensive Regimen</brief_title>
	<detailed_description />
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Antihypertensive Agents</mesh_term>
	<criteria>Age &gt; 45 year Increased waist circumference ( &gt; 88.9cm [ &gt; 35in ] men , &gt; 78.7cm [ &gt; 31in ] woman ) Elevated triglyceride ( &gt; 150mg/dl ) Low HDL cholesterol ( &lt; 40mg/dl men , &lt; 50mg/dl woman ) Hypertension ( &gt; 130/ &gt; 85mmHG ) Impaired fast glucose ( &gt; 110mg/dl ) ( 8 ) Hypertensive patient assess benefit telmisartan base treatment Hypersensitivity telmisartan , hydrochlorothiazide ( HCTZ ) excipients &lt; 3 month myocardial infarction ( MI ) , stroke severe heart failure</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>